These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 28272677)
21. An immunohistochemical and molecular analysis of problematic and unclassified ovarian sex cord-stromal tumors. Stewart CJ; Alexiadis M; Crook ML; Fuller PJ Hum Pathol; 2013 Dec; 44(12):2774-81. PubMed ID: 24134930 [TBL] [Abstract][Full Text] [Related]
22. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations. Croce S; de Kock L; Boshari T; Hostein I; Velasco V; Foulkes WD; McCluggage WG Int J Gynecol Pathol; 2016 Jul; 35(4):301-8. PubMed ID: 26598979 [TBL] [Abstract][Full Text] [Related]
23. Lack of mutation of DICER1 and FOXL2 genes in microcystic stromal tumor of the ovary. Meurgey A; Descotes F; Mery-Lamarche E; Devouassoux-Shisheboran M Virchows Arch; 2017 Feb; 470(2):225-229. PubMed ID: 27830327 [TBL] [Abstract][Full Text] [Related]
24. Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin. Deavers MT; Malpica A; Liu J; Broaddus R; Silva EG Mod Pathol; 2003 Jun; 16(6):584-90. PubMed ID: 12808064 [TBL] [Abstract][Full Text] [Related]
25. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary. Onder S; Hurdogan O; Bayram A; Yilmaz I; Sozen H; Yavuz E Virchows Arch; 2021 Aug; 479(2):317-324. PubMed ID: 33566167 [TBL] [Abstract][Full Text] [Related]
26. Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network. Maillet D; Goulvent T; Rimokh R; Vacher-Lavenu MC; Pautier P; Alexandre J; Pujade-Laurraine E; Devouassoux-Shisheboran M; Treilleux I; Ray-Coquard I; Savina A Gynecol Oncol; 2014 Jan; 132(1):181-7. PubMed ID: 24157616 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical staining for calretinin is useful in the diagnosis of ovarian sex cord-stromal tumours. McCluggage WG; Maxwell P Histopathology; 2001 May; 38(5):403-8. PubMed ID: 11422476 [TBL] [Abstract][Full Text] [Related]
28. Steroidogenic acute regulatory protein is a useful marker for Leydig cells and sex-cord stromal tumors. Dong L; Wang H; Su Z; Niu S; Wang R; Wu L; Chen G Appl Immunohistochem Mol Morphol; 2011 May; 19(3):226-32. PubMed ID: 21217523 [TBL] [Abstract][Full Text] [Related]
29. Fascin can be an auxiliary immunomarker of ovarian granulosa cell tumors: comparison with calretinin and inhibin-alpha. Kostopoulou E; Angelidou S; Daponte A; Galani C; Chiotoglou I; Terzis A; Koukoulis G Eur J Gynaecol Oncol; 2008; 29(6):638-42. PubMed ID: 19115695 [TBL] [Abstract][Full Text] [Related]
30. Alpha and beta subunits of inhibin/activin as sex cord-stromal differentiation markers. Zheng W; Sung CJ; Hanna I; DePetris G; Lambert-Messerlian G; Steinhoff M; Lauchlan SC Int J Gynecol Pathol; 1997 Jul; 16(3):263-71. PubMed ID: 9421093 [TBL] [Abstract][Full Text] [Related]
31. Value of inhibin staining in gynecological pathology. McCluggage WG Int J Gynecol Pathol; 2001 Jan; 20(1):79-85. PubMed ID: 11192074 [TBL] [Abstract][Full Text] [Related]
32. SF-1 is a diagnostically useful immunohistochemical marker and comparable to other sex cord-stromal tumor markers for the differential diagnosis of ovarian sertoli cell tumor. Zhao C; Barner R; Vinh TN; McManus K; Dabbs D; Vang R Int J Gynecol Pathol; 2008 Oct; 27(4):507-14. PubMed ID: 18753972 [TBL] [Abstract][Full Text] [Related]
33. Inhibin is more specific than calretinin as an immunohistochemical marker for differentiating sarcomatoid granulosa cell tumour of the ovary from other spindle cell neoplasms. Shah VI; Freites ON; Maxwell P; McCluggage WG J Clin Pathol; 2003 Mar; 56(3):221-4. PubMed ID: 12610103 [TBL] [Abstract][Full Text] [Related]
34. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study. Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501 [TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical study of testicular sex cord-stromal tumors, including staining with anti-inhibin antibody. McCluggage WG; Shanks JH; Whiteside C; Maxwell P; Banerjee SS; Biggart JD Am J Surg Pathol; 1998 May; 22(5):615-9. PubMed ID: 9591732 [TBL] [Abstract][Full Text] [Related]
36. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours. Rabban JT; Zaloudek CJ Histopathology; 2013 Jan; 62(1):71-88. PubMed ID: 23240671 [TBL] [Abstract][Full Text] [Related]
37. Müllerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors. Matias-Guiu X; Pons C; Prat J Hum Pathol; 1998 Aug; 29(8):840-5. PubMed ID: 9712426 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of inhibin immunoreactivity in ovarian gonadal stromal tumours and their histological mimics. Stewart CJ; Jeffers MD; Kennedy A Histopathology; 1997 Jul; 31(1):67-74. PubMed ID: 9253627 [TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical characterization of nonhuman primate ovarian sex cord-stromal tumors. Durkes A; Garner M; Juan-Sallés C; Ramos-Vara J Vet Pathol; 2012 Sep; 49(5):834-8. PubMed ID: 22273575 [TBL] [Abstract][Full Text] [Related]
40. Inhibin alpha and beta expression in ovarian stromal tumors and their histological equivalences. Ciriş M; Erhan Y; Zekioglu O; Bayramoglu H Acta Obstet Gynecol Scand; 2004 May; 83(5):491-6. PubMed ID: 15059165 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]